HN2001000281A - Nuevas imidazotriazinonas sustituidas - Google Patents

Nuevas imidazotriazinonas sustituidas

Info

Publication number
HN2001000281A
HN2001000281A HN2001000281A HN2001000281A HN2001000281A HN 2001000281 A HN2001000281 A HN 2001000281A HN 2001000281 A HN2001000281 A HN 2001000281A HN 2001000281 A HN2001000281 A HN 2001000281A HN 2001000281 A HN2001000281 A HN 2001000281A
Authority
HN
Honduras
Prior art keywords
replaced
new
imidazotriazinonas
preparation
capacity
Prior art date
Application number
HN2001000281A
Other languages
English (en)
Inventor
Niewohner Ulrich
Dagmar Schaub
Martin Hendrix
Gerhard Konig
Frank Gerhard Bob
Franz Josef
Van Der Staay
Rudy Schreiber
Schlemmer Karl-Heinz
Rolf Grosser
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of HN2001000281A publication Critical patent/HN2001000281A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVAS IMIDAZOTRIAZINONAS SUSTITUIDAS., A PROCEDIMIENTOS PARA SU PREPARACION Y SU USO PARA LA PREPARACION DE MEDICAMENTOS, ESPECIALMENTE PARA LA MEJORA DE LA PERCECCION, LA CAPACIDAD DE APRENDIZAJE Y/O CAPACIDAD DE MEMORIA.
HN2001000281A 2000-12-21 2001-12-19 Nuevas imidazotriazinonas sustituidas HN2001000281A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10064105A DE10064105A1 (de) 2000-12-21 2000-12-21 Neue Substituierte Imidazotriazinone

Publications (1)

Publication Number Publication Date
HN2001000281A true HN2001000281A (es) 2003-02-04

Family

ID=7668333

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2001000281A HN2001000281A (es) 2000-12-21 2001-12-19 Nuevas imidazotriazinonas sustituidas

Country Status (15)

Country Link
US (1) US6573263B2 (es)
EP (1) EP1347978B1 (es)
JP (1) JP2004525098A (es)
AR (1) AR034423A1 (es)
AU (1) AU2002216087A1 (es)
CA (1) CA2431965A1 (es)
DE (2) DE10064105A1 (es)
DO (1) DOP2001000297A (es)
ES (1) ES2248228T3 (es)
GT (1) GT200100254A (es)
HN (1) HN2001000281A (es)
PE (1) PE20020756A1 (es)
SV (1) SV2002000776A (es)
UY (1) UY27080A1 (es)
WO (1) WO2002050078A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113342D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 1
US7087605B2 (en) 2001-06-01 2006-08-08 Bayer Aktiengesellschaft 5-Ethyl-imidazotriazinones
PL372295A1 (en) * 2002-02-04 2005-07-11 F.Hoffmann-La Roche Ag Quinoline derivatives as npy antagonists
BR0312461A (pt) * 2002-07-05 2005-04-26 Hoffmann La Roche Compostos, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo, sua utilização e métodos para tratamento e profilaxia
EP1539722A1 (en) * 2002-08-07 2005-06-15 F. Hoffmann-La Roche Ag Thiazole derivatives
JP2006219374A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Ｐｄｅ７阻害作用を有するイミダゾトリアジノン誘導体
KR20150005936A (ko) 2012-04-25 2015-01-15 다케다 야쿠힌 고교 가부시키가이샤 질소화 헤테로시클릭 화합물
US9527841B2 (en) 2012-07-13 2016-12-27 Takeda Pharmaceutical Company Limited Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors
WO2014142255A1 (ja) 2013-03-14 2014-09-18 武田薬品工業株式会社 複素環化合物
JP6411342B2 (ja) 2013-07-03 2018-10-24 武田薬品工業株式会社 アミド化合物
US10053468B2 (en) 2013-07-03 2018-08-21 Takeda Pharmaceutical Company Limited Heterocyclic compound
US9815796B2 (en) 2013-12-23 2017-11-14 Merck Sharp & Dohme Corp. Pyrimidone carboxamide compounds as PDE2 inhibitors
US9849132B2 (en) 2014-01-08 2017-12-26 Intra-Cellular Therapies, Inc. Products and pharmaceutical compositions
NZ725161A (en) 2014-04-23 2017-10-27 Dart Neuroscience (Cayman) Ltd Substituted [1,2,4] triazolo [1,5-a] pyrimidin-7-yl compounds as pde2 inhibitors
US10239882B2 (en) 2014-11-05 2019-03-26 Dart Neuroscience (Cayman) Ltd. Substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as PDE2 inhibitors
US10300064B2 (en) 2014-12-06 2019-05-28 Intra-Cellular Therapies, Inc. Organic compounds
WO2016090382A1 (en) 2014-12-06 2016-06-09 Intra-Cellular Therapies, Inc. Organic compounds
WO2016145614A1 (en) 2015-03-17 2016-09-22 Merck Sharp & Dohme Corp. Triazolyl pyrimidinone compounds as pde2 inhibitors
EP3285581B1 (en) 2015-03-26 2021-08-11 Merck Sharp & Dohme Corp. Pyrazolyl pyrimidinone compounds as pde2 inhibitors
WO2016179059A1 (en) 2015-05-05 2016-11-10 Merck Sharp & Dohme Corp. Heteroaryl-pyrimidinone compounds as pde2 inhibitors
WO2016183741A1 (en) 2015-05-15 2016-11-24 Merck Sharp & Dohme Corp. Pyrimidinone amide compounds as pde2 inhibitors
WO2016191935A1 (en) 2015-05-29 2016-12-08 Merck Sharp & Dohme Corp. 6-alkyl dihydropyrazolopyrimidinone compounds as pde2 inhibitors
WO2016192083A1 (en) 2015-06-04 2016-12-08 Merck Sharp & Dohme Corp. Dihydropyrazolopyrimidinone compounds as pde2 inhibitors
EP3313852B1 (en) 2015-06-25 2021-01-20 Merck Sharp & Dohme Corp. Substituted pyrazolo/imidazolo bicyclic compounds as pde2 inhibitors
WO2017000277A1 (en) 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Substituted triazolo bicycliccompounds as pde2 inhibitors
WO2017000276A1 (en) 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Bicyclic heterocyclic compounds as pde2 inhibitors
CN111447930A (zh) 2017-11-23 2020-07-24 奥斯陆大学医院公司 心动过速的治疗

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK109578A (da) 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
DE19541264A1 (de) 1995-11-06 1997-05-07 Bayer Ag Purin-6-on-derivate
DE19709877A1 (de) 1997-03-11 1998-09-17 Bayer Ag 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
UA46166C2 (uk) * 1997-11-12 2002-05-15 Баєр Акцієнгезельшафт 2-фенілзаміщені імідазотриазинони як інгібітори фосфодіестерази, спосіб їх одержання та лікарський засіб на їх основі
DE19827640A1 (de) 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
DE19838705A1 (de) 1998-08-26 2000-03-02 Bayer Ag Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one

Also Published As

Publication number Publication date
US6573263B2 (en) 2003-06-03
AU2002216087A1 (en) 2002-07-01
US20020198377A1 (en) 2002-12-26
EP1347978A1 (de) 2003-10-01
UY27080A1 (es) 2002-07-31
CA2431965A1 (en) 2002-06-27
SV2002000776A (es) 2002-12-02
EP1347978B1 (de) 2005-08-31
DE50107316D1 (de) 2005-10-06
JP2004525098A (ja) 2004-08-19
AR034423A1 (es) 2004-02-25
GT200100254A (es) 2002-08-19
DE10064105A1 (de) 2002-06-27
DOP2001000297A (es) 2003-08-15
WO2002050078A1 (de) 2002-06-27
ES2248228T3 (es) 2006-03-16
PE20020756A1 (es) 2002-10-02

Similar Documents

Publication Publication Date Title
HN2001000281A (es) Nuevas imidazotriazinonas sustituidas
ITTO20010005A1 (it) Formulazione farmaceutica.
MA26937A1 (fr) Nouvelle composition pharmaceutique.
NL1015859A1 (nl) Farmaceutische preparaten.
HN2001000006A (es) Antagonistas del factor liberador de corticotropina
HN2002000300A (es) Nuevos derivados de piperazina
NO20032438D0 (no) Orto- og metasubstituerte bis-arylforbindelser, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
MXPA03001425A (es) Compuestos farmaceuticos.
UY28312A1 (es) Pirazolopirimidinas sustituidas con 6-ciclimetilo y 6-alquilmetilo
HN2001000235A (es) Derivados puentes de piperazina
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
BR0110478B1 (pt) composiÇço aquosa de xampu.
SV2002000639A (es) Alcanosulfonatos de fenoxifenilo ref. lea 34813-sv
MXPA03001857A (es) Composicones medicinales.
ITTO20011197A0 (it) Corpo cilindrico ornamentale.
ES1047631Y (es) Dispositivo para la fabricacion de piezas modulares para la construccion.
ES1047263Y (es) Tabla para escritura braille.
ES1047426Y (es) Cuerpo intermedio para linternas.
HN1999000128A (es) Nuevos usos farmaceuticos para inhibidores nos.
ES1048007Y (es) Electrodo para aplicacion cutanea.
ES1046210Y (es) Pieza para sujeccion de estructuras de invernaderos.
IT1320769B1 (it) Gel vaginale.
BR0104878B1 (pt) vaporizador direcional de uso humano.
ES1046474Y (es) Tijeras ambidiestras.